Kelyniam Global, Inc. operates as a medical device manufacturing company, which engages in the production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The company is headquartered in Little Rock, Arkansas. The company went IPO on 2008-04-03. The firm is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient’s computed tomography (CT) data, its 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours. The company distributes its products throughout the United States via independent distributors and sales representatives.
Follow-Up Questions
Quel est le ratio P/E de Kelyniam Global Inc (KLYG) ?
Le ratio P/E de Kelyniam Global Inc est de N/A
Quelle est la performance du prix de l'action KLYG ?
Le prix actuel de KLYG est de 0.066, il a decreased de 0% lors de la dernière journée de trading.
Quelle est la capitalisation boursière de Kelyniam Global Inc ?
La capitalisation boursière actuelle de Kelyniam Global Inc est de $3.2
Est-ce que Kelyniam Global Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 0 analystes ont établi des notations d'analystes pour Kelyniam Global Inc, y compris 0 achat fort, 0 achat, 0 maintien, 0 vente et 0 vente forte
